LYTIR

Insider · SEC Form 4 · Chief Medical Officer

Hendrik Peter Scholl

Filed with the SEC as Scholl Hendrik Peter; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: sold $3.3M of BLTE. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $3.3M in total.Jun: Insider sales $2.9MOct: Insider sales $83KNov: Insider sales $332KDecJanFebMarAprMayJunJulAugSepOctNov$2.9M
Insider purchases above the line: $0Insider sales below: $3.3M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. BLTESold: BELITE BIO, INC Nov 12, 2026 2,000 shares filed Nov 16, 2026 4 transactions 10b5-1 plan filing $332K
  2. BLTESold: BELITE BIO, INC Oct 1, 2026 500 shares filed Oct 5, 2026 8 transactions 10b5-1 plan filing $83K
  3. BLTESold: BELITE BIO, INC Jun 18, 2026 10,000 shares filed Jun 22, 2026 5 transactions filing $1.5M
  4. BLTESold: BELITE BIO, INC Jun 16, 2026 10,000 shares filed Jun 17, 2026 8 transactions filing $1.4M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. BLTEHendrik Peter Scholl filed Oct 1, 2026 BELITE BIO, INC Officer 4,000 shares planned sale date 10/01/2026 filing $679K